THERAPEUTISCHE DOSIERUNG EINES NEUREGULINS IN DER BEHANDLUNG ODER PROPHYLAXE VON HERZVERSAGEN

European patent · EP3338791 · Deleted

Register entry

Publication number
EP3338791
Application number
EP17209369
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 17, 2009
Published
Jun 27, 2018
Granted
Sep 18, 2019
Deleted
Feb 23, 2023
Reason
Annual fee unpaid
IPC classes
A61K 38/18 (2006.01)
A61P 9/00 (2006.01)
Priority
US 135171 P 17.07.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 23, 2023

    Deleted, fee unpaid

    Published in Swissreg on 23.02.2023

  2. Sep 22, 2021

    Further processing requested

    Published in Swissreg on 22.09.2021

  3. Mar 10, 2021

    Further processing requested

    Published in Swissreg on 10.03.2021

  4. Feb 17, 2021

    Deleted, fee unpaid

    Published in Swissreg on 17.02.2021

  5. Dec 14, 2019

    Agent entered

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 14.12.2019

  6. Sep 18, 2019

    Granted

    Published in Swissreg on 18.09.2019

Parties

Holder

Acorda Therapeutics, Inc.

420 Saw Mill River Road, Ardsley, NY 10502, US

Agent

Dr. Lusuardi AG

Kreuzbühlstrasse 8, 8008 Zürich

Inventor

CAGGIANO, Anthony

Larchmont NJ New Jersey, US

IACI, Jennifer

Boonton NJ New Jersey 07005, US

PARRY, Tom

Hellertown PA Pennsylvania 18055, US

GANGULY, Anindita

White Plains NY New York 10605, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.